Yantai Dongcheng Pharmaceutical Co Ltd Tangible Net Worth Ratio
Yantai Dongcheng Pharmaceutical Co Ltd tangible net worth ratio. Yantai Dongcheng Pharmaceutical Co Ltd (002675) has a Tangible Net Worth Ratio of 89.3% as of March 2026. This metric is calculated by deducting intangible assets (CN¥578.42 Million) from net assets (CN¥5.40 Billion) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. Also explore how fast is Yantai Dongcheng Pharmaceutical Co Ltd growing its equity to track the company's year-over-year net asset growth rate.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Tangible Net Worth Ratio of Yantai Dongcheng Pharmaceutical Co Ltd (2008–2025)
Tangible net worth ratio of Yantai Dongcheng Pharmaceutical Co Ltd from 2008 to 2025. This chart shows how Yantai Dongcheng Pharmaceutical Co Ltd's Tangible Net Worth Ratio has changed across 18 annual periods from 2008 to 2025. As of March 2026, the ratio stands at 89.3%, reflecting net assets of CN¥5.40 Billion with intangible assets of CN¥578.42 Million CNY. Check Yantai Dongcheng Pharmaceutical Co Ltd strategic capital allocation to assess the company's strategic physical and investment asset allocation.
Yantai Dongcheng Pharmaceutical Co Ltd Tangible Net Worth Ratio by Year (2008–2025)
Yantai Dongcheng Pharmaceutical Co Ltd tangible net worth ratio by year from 2008 to 2025. The table below presents the year-by-year Tangible Net Worth Ratio for Yantai Dongcheng Pharmaceutical Co Ltd from 2008 to 2025, covering 18 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For live market cap and overall valuation, see Yantai Dongcheng Pharmaceutical Co Ltd market cap and net worth.
| Year | Tangible NW Ratio | Net Assets (CNY) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 90.0% | CN¥5.66 Billion | CN¥567.83 Million | CN¥9.26 Billion | ▼ -0.4 pp |
| 2024 | 90.4% | CN¥5.37 Billion | CN¥518.23 Million | CN¥8.63 Billion | ▼ -1.8 pp |
| 2023 | 92.1% | CN¥5.40 Billion | CN¥425.36 Million | CN¥8.08 Billion | ▼ -1.8 pp |
| 2022 | 93.9% | CN¥5.28 Billion | CN¥321.97 Million | CN¥8.18 Billion | ▲ +0.1 pp |
| 2021 | 93.8% | CN¥5.02 Billion | CN¥308.97 Million | CN¥7.66 Billion | ▼ -0.5 pp |
| 2020 | 94.4% | CN¥4.97 Billion | CN¥279.43 Million | CN¥7.39 Billion | ▼ -0.3 pp |
| 2019 | 94.7% | CN¥4.78 Billion | CN¥255.22 Million | CN¥7.29 Billion | ▼ -0.1 pp |
| 2018 | 94.7% | CN¥4.61 Billion | CN¥243.24 Million | CN¥6.97 Billion | ▲ +1.0 pp |
| 2017 | 93.7% | CN¥3.29 Billion | CN¥205.86 Million | CN¥5.27 Billion | ▼ -1.0 pp |
| 2016 | 94.8% | CN¥3.08 Billion | CN¥161.73 Million | CN¥4.27 Billion | ▼ -0.4 pp |
| 2015 | 95.2% | CN¥2.24 Billion | CN¥108.06 Million | CN¥2.55 Billion | ▲ +1.6 pp |
| 2014 | 93.6% | CN¥1.18 Billion | CN¥76.11 Million | CN¥1.39 Billion | ▼ -0.3 pp |
| 2013 | 93.8% | CN¥1.10 Billion | CN¥67.82 Million | CN¥1.23 Billion | ▼ -2.3 pp |
| 2012 | 96.1% | CN¥1.02 Billion | CN¥39.42 Million | CN¥1.09 Billion | ▼ -0.6 pp |
| 2011 | 96.7% | CN¥304.42 Million | CN¥10.04 Million | CN¥451.24 Million | ▲ +2.1 pp |
| 2010 | 94.6% | CN¥191.06 Million | CN¥10.30 Million | CN¥359.19 Million | ▲ +1.6 pp |
| 2009 | 93.1% | CN¥140.43 Million | CN¥9.76 Million | CN¥266.96 Million | ▲ +5.8 pp |
| 2008 | 87.2% | CN¥79.34 Million | CN¥10.12 Million | CN¥195.09 Million | — |